Deva Holding A.S.
DEVA
Rank in Stocks
#14558
Deva Holding A.S. is a Turkish pharmaceutical firm specializing in the... Deva Holding A.S. is a Turkish pharmaceutical firm specializing in the development and distribution of a wide array of medicinal goods. Its extensive portfolio encompasses treatments for various conditions, including cancer (antineoplastic agents), immune system disorders (immunomodulating agents), skin ailments (dermatological products), hormonal imbalances (systemic hormonal preparations), and infectious or parasitic diseases (anti-infective and antiparasitic products for systemic use). Additionally, the company offers dietary supplements and electrolyte solutions. Deva Holding also supplies pharmaceuticals targeting major bodily systems such as the urogenital and reproductive systems, blood and hematopoietic organs, the cardiovascular system, musculoskeletal system, nervous system, digestive tract and metabolism, respiratory system, and sensory organs. Furthermore, its offerings include specific drug classes like cephalosporins and penicillin, inhalation therapies, both solid and liquid oncological preparations, and veterinary pharmaceuticals. It also produces active pharmaceutical ingredients (APIs), various sterile dosage forms such as ampoules, liquid and lyophilized vials, and ophthalmic drops, alongside medical ampoules for sterile injectables; cologne is also part of its product line. Beyond its domestic operations, Deva Holding exports its products to approximately 60 nations globally. Established in 1958, the company maintains its headquarters in Istanbul, Turkey, and operates as a subsidiary of Eastpharma S.Γ R.L.
Share Price
$1.58
Last synced: 2026-11-09
Market Cap
$316.26M
Change (1 day)
-1.47%
Change (1 year)
6.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Deva Holding A.S. (DEVA)
Category
Healthcare
P/S ratio for Deva Holding A.S. (DEVA)
P/S ratio as of November 2026 TTM: 0.63
According to Deva Holding A.S.'s latest financial reports and stock price, its current price-to-sales ratio (TTM) is 0.63. At the end of 2025 the company had a P/S ratio of 0.65.
P/S ratio history for Deva Holding A.S. from 2005 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 0.63 | -2.62% |
| 2025 | 0.65 | -35.95% |
| 2024 | 1.02 | -26.68% |
| 2023 | 1.39 | -55.11% |
| 2022 | 3.09 | 25.31% |
| 2021 | 2.47 | -4.81% |
| 2020 | 2.59 | 98.01% |
| 2019 | 1.31 | 106.94% |
| 2018 | 0.63 | -42.24% |
| 2017 | 1.09 | 7.05% |
| 2016 | 1.02 | -24.04% |
| 2015 | 1.35 | 49.99% |
| 2014 | 0.90 | 1.50% |
| 2013 | 0.88 | -11.25% |
| 2012 | 1.00 | 14.33% |
| 2011 | 0.87 | -29.16% |
| 2010 | 1.23 | 61.61% |
| 2009 | 0.76 | -39.38% |
| 2008 | 1.26 | -25.72% |
| 2007 | 1.69 | 19.52% |
| 2006 | 1.41 | -12.00% |
| 2005 | 1.61 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 2.82 | 345.58% |
DE
|
|
| 3.11 | 391.71% |
DE
|
|
| 2.26 | 257.63% |
JP
|
|
| 9.32 | 1,372.51% |
CH
|
|
| 2.73 | 331.50% |
IL
|
Questions about Deva Holding A.S.'s P/S ratio
What is Deva Holding A.S.'s P/S ratio?
Deva Holding A.S.'s P/S ratio is 0.63, as of Nov 2026.
What was Deva Holding A.S.'s P/S ratio in 2025?
In 2025, Deva Holding A.S.'s P/S ratio was 0.65, compared with 1.02 in 2024.
How has Deva Holding A.S.'s P/S ratio changed since 2020?
From 2020 to 2025, Deva Holding A.S.'s P/S ratio was highest in 2022 (3.09) and lowest in 2025 (0.65).
How does Deva Holding A.S.'s P/S ratio compare with similar companies?
Deva Holding A.S.'s P/S ratio (0.63) is lower than that of all 5 similar companies listed above. The highest among them is Galderma Group AG, with 9.32.